| Literature DB >> 35599689 |
Nadine Ostern1, Guido Perscheid2, Caroline Reelitz2, Jürgen Moormann2.
Abstract
Background: Accelerated by the coronavirus disease 2019 (Covid-19) pandemic, major and lasting changes are occuring in healthcare structures, impacting people's experiences and value creation in all aspects of their lives. Information systems (IS) research can support analysing and anticipating resulting effects. Aim: The purpose of this study is to examine in what areas health information systems (HIS) researchers can assess changes in healthcare structures and, thus, be prepared to shape future developments. Method: A hermeneutic framework is applied to conduct a literature review and to identify the contributions that IS research makes in analysing and advancing the healthcare industry.Entities:
Keywords: Health information systems research; Healthcare; Research agenda
Year: 2021 PMID: 35599689 PMCID: PMC8285287 DOI: 10.1007/s12525-021-00484-1
Source DB: PubMed Journal: Electron Mark ISSN: 1019-6781
Fig. 1Hermeneutic procedure applied to the literature review
Fig. 2Steps of the search process to create the data set
HIS publications assigned to the phase of problem identification and research issues
HIS publications assigned to the definition of research objectives and solution space
HIS publications assigned to the design and development phase
HIS publications assigned to the demonstration phase
HIS publications assigned to the evaluation phase
Agenda for a comprehensive research approach for future HIS-research
| Areas of improvement | Guiding statements for future HIS research | Exemplary research questions and exemplary studies | Pathway |
|---|---|---|---|
| Anticipate the range of actor behaviours | • Determine existing and emergent actors in the healthcare industry • Identify actors’ interests and strategies in joining or staying in the healthcare industry • Align interests of established and new actors to achieve patient-centricity | • Why do companies engage in activities that lead to the blurring of industry boundaries (Nicholls-Nixon & Jasinski, • Does the nature of boundary-crossing actions differ between firms (i.e., what is the value driver that leads companies into the healthcare industry) (Akkerman & Bakker, • Does the infiltration of new actors into the healthcare system promote organizational learning for the benefit of the patient (Rivard et al., | Pathway 1, Pathway 3 |
| Determine boundaries and foster collaboration | • Capture and describe the blurring boundaries of the healthcare industry • Harness the advantages of blurring industry boundaries by proposing and developing appropriate ecosystem infrastructures • Create open systems that enable radical digital innovation | • How, and to what extent, do deregulation, globalization, and breakthroughs in science and information technology contribute to the blurring of boundaries (Rycroft & Kash, • How can we leverage multi-company ecosystems with varying value propositions (Schwetschke & Durugbo, • How is cross- and inter-industry innovation fostered, such as through absorptive potential or creative imitation (Enkel & Gassmann, | Pathway 2 |
| Create sustainable knowledge ecosystems | • Design and maintain permeable knowledge management systems for information interchange between actors in the healthcare industry • Implement structures of mutual benefit while protecting intellectual property rights • Ensure patient privacy while creating systems that allow for trustworthy predictions | • How should (knowledge and data) management systems be designed in order to balance information provision and privacy issues (Shahmoradi et al., • Can we increase technology and information transfer by introducing appropriate intellectual property rights in the healthcare industry? (Fisman et al., | Pathway 4 |